UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Cambridge Advisors Inc.

Cambridge Advisors Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,122 shares of the healthcare conglomerate's stock after selling 685 shares during the period. Cambridge Advisors Inc.'s holdings in UnitedHealth Group were worth $1,073,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC bought a new stake in UnitedHealth Group in the third quarter valued at about $32,000. Quarry LP boosted its stake in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock valued at $33,000 after buying an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $37,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.1 %

UnitedHealth Group stock traded down $0.56 during mid-day trading on Monday, hitting $510.03. The company's stock had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a 50 day moving average of $549.37 and a 200-day moving average of $563.70. The stock has a market cap of $469.37 billion, a PE ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $5.83 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's dividend payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. StockNews.com cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Wednesday, January 15th. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research note on Thursday, December 5th. Finally, Morgan Stanley lowered their target price on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a research note on Wednesday, October 16th. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.